Abstract
BackgroundRheumatology patients with autoimmune inflammatory rheumatic diseases on major DMARDs and/or biologics are at increased risk of infection because of ill-defined immunoregulatory state as well as immunosuppressive drugs. Vaccination against...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
